Sanofi in the news

Sanofi pursues sale of France's leading painkiller to US investment fund after controversy

Read on: France 24

Sanofi joins rivals investing in nuclear cancer treatment

Read on: Financial Times

Deal to sell Sanofi unit to US fund deals new blow to French govt

Read on: Daily Sabah

Sanofi deal offers only partial headache relief

Read on: Financial Times

France takes stake in Sanofi unit as part of EUR16bn sale to CDR

Read on: Financial Times

Pharmaceutical giant Sanofi looks to sell consumer health unit, sparks political uproar

Read on: France 24

France warns it could block EUR15.5bn Sanofi consumer health deal

Read on: Financial Times

Sanofi in Talks to Sell Controlling Stake in Consumer Health Arm to CDR

Read on: The Wall Street Journal

Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker

Read on: CNBC News

Sanofi licensing deal doubles value of vaccine group Novavax

Read on: Financial Times

Novavax shares nearly double on Sanofi deal to commercialize Covid vaccine, develop combination shots

Read on: CNBC News

Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi

Read on: Quartz

Sanofi Sales, Profit Beat Forecasts

Read on: The Wall Street Journal

Sanofi to Settle Claims That Heartburn Drug Zantac Caused Cancer

Read on: The Wall Street Journal

Sanofi to strengthen India footprint, product pipeline

Read on: Times of India

CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage

Read on: CNBC News